New application of phosphodiesterase-5 inhibitors in uro-andrology.
- Author:
Zheng LI
1
;
Hui LU
Author Information
1. Department of Urology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai Human Sperm Bank, Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai 200135, China. Lizhengboshi@163.com
- Publication Type:Journal Article
- MeSH:
Humans;
Lower Urinary Tract Symptoms;
drug therapy;
Male;
Phosphodiesterase 5 Inhibitors;
therapeutic use;
Reperfusion Injury;
drug therapy;
Spermatic Cord Torsion;
drug therapy;
Treatment Outcome
- From:
National Journal of Andrology
2013;19(8):675-677
- CountryChina
- Language:Chinese
-
Abstract:
Phosphodiesterase type 5 (PDE5) inhibitors are the most classic first-line medicine for male erectile dysfunction. Recent researches have demonstrated that PDE5 inhibitors can also be employed in the treatment of lower urinary tract symptoms, renal ischemia/reperfusion injury and testicular torsion. This article updates the application of PDE5 inhibitors in these fields and their relevant mechanisms.
